Working to effectively end AIDS and cervical cancer.
HIV-positive women screened for cervical cancer
Are women screened for the first time
Women living with HIV in the eight Go Further target countries
An Oral History of PEPFAR: How a "Dream Big" Partnership is Saving the Lives of Millions
Policy Recommendations: Improving Health and Security Around the WorldGlobal health -- it's no time to quit
George W. Bush: PEPFAR saves millions of lives in Africa. Keep it fully funded.
President and Mrs. Bush's Visit to Namibia and Botswana in PhotosThey delivered a message to Congress and all Americans: lives in Africa matter.
The Lazarus Effect, 15 Years Later
Women living with HIV are five times more likely to develop cervical cancer. The Bush Institute, together with its partners PEPFAR, UNAIDS, and Merck developed a strategy to save women's lives in sub-Saharan African countries with a high burden of HIV and cervical cancer.
Launched in May 2018, Go Further is an innovative public-private partnership committed to creating a healthier future for women. The partnership aims to reduce new cervical cancer cases by 95 percent among HIV-positive women in eight African countries that have some of the highest rates of HIV prevalence and cervical cancer incidence in the world.
Go Further invests in partner countries to integrate and scale up cervical cancer screening and treatment services within existing platforms for HIV treatment and women's health. The Bush Institute and PEPFAR have partnered in this space since 2011, and since Go Further was launched in 2018, PEPFAR has invested over $53 million in cervical cancer screening and treatment for HIV-positive women.
The success of this program is made possible by the thousands of mothers, sisters, and daughters who bravely confront HIV and cervical cancer diagnoses every day.
- More than 500,000 women have been screened for cervical cancer
- For 420,000 of these women, this was their first cervical cancer screening
- Nearly 40,000 screened women were found to have pre-cancerous lesions or suspected cancer
- 65% of those with pre-cancerous lesions have received treatment – we are working to scale our efforts
Women living with HIV are five times more likely to develop cervical cancer
Cervical cancer is the number one cancer killer of women in Sub-Saharan Africa
Number of women in Sub-Saharan Africa diagnosed with cervical cancer each year
CommentaryLatest Articles View all
Cervical cancer survivor Lydia Musonda shares her story at Concordia Summit
How to avoid future threats of rescission: follow the principles of PEPFAR
The importance of political leadership in the fight against cervical cancer
Tackling TB and HIV in Women
A roadmap to fight cervical cancer
Two-Minute Take: World Cancer Day
Global Leadership: A Look Back at 2018
Partnerships based on trust get results, and Namibia is proof
In the NewsLatest Press Releases & Headlines View all
Go Further Partnership Reaches Over Half a Million HIV-Positive Women with Cervical Cancer Screening in its First Year
George W. Bush Institute, PEPFAR, and UNAIDS Announce Partnership to End Aids and Cervical Cancer
Bono Awarded George W. Bush Medal for Distinguished Leadership for AIDS Work
U2's Bono receives first George W. Bush Medal, pays tribute to late Barbara Bush
U2's Bono says Barbara Bush made George W. an 'AIDS activist'
Bono receives the George W. Bush medal for leadership for his work on poverty and disease
First ladies lead fight against AIDS
Bono to come to Dallas to receive leadership award from George W. Bush
Bono to Receive First-Ever George W. Bush Medal for Distinguished Leadership
Bono to get leadership award from Bush Center